NCT02121054已完成不适用
Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease
Young-Hak Kim, MD, PhD1 个研究点 分布在 1 个国家目标入组 1,527 人开始时间: 2013年10月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,527
- 试验地点
- 1
- 主要终点
- Major adverse event
研究概览
简要总结
The purpose of this study is to evaluate the prognosis of patients with resistance to antiplatelet agent and develop tailored treatment model for patients with coronary artery disease.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with coronary artery disease
- •Patients with peripheral artery disease
排除标准
- •Renal dysfunction
- •Hepatic dysfunction
- •Major surgery planned within 1 year
- •Malignant tumor
- •History of gastrointestinal bleeding
- •low or high platelet count
结局指标
主要结局
Major adverse event
时间窗: 2 year
Major adverse event : overall mortality, cardiovascular mortality, target vessel revascularization
次要结局
- Biomarker(2 year)
研究者
Young-Hak Kim, MD, PhD
MD, PhD
Asan Medical Center
研究点 (1)
Loading locations...
相似试验
Temporarily Not Available
不适用
Clopidogrel Resistance and the Possibility of Its AffectionCoronary Artery DiseaseNCT00839345Charles University, Czech Republic
已完成
不适用
Antiplatelet Resistance Research in Patients With Peripheral Arterial RevascularizationVascular DiseasesNCT03953547Fondation Hôpital Saint-Joseph88
Unknown
不适用
Platelet Function in Patients With an Acute Coronary SyndromeAcute Coronary Syndrome (ACS)NCT01992484Medical University of Vienna1,000
尚未招募
Unknown
Assessment of Antiplatelet resistance like aspirin and clopidogrel in patients with Ischemic stroke using Thromboelastogram Platelet MappingCTRI/2023/07/055555Gleneagles Global Hospital
已完成
不适用
Antiplatelet Drug Resistances and Ischemic EventsSymptomatic AtherothrombosisNCT00501423Pierre Fontana771